IRMA PEREZ: Open Payments
NPI 1699199570 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 53 payments from 19 companies in 2025. Trend: 2023 $1,188 · 2024 $1,092 · 2025 $1,136
Food & beverage: $1,136
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $252 |
| PFIZER INC. | 12 | $180 |
| AstraZeneca Pharmaceuticals LP | 2 | $161 |
| MERZ NORTH AMERICA, INC. | 1 | $117 |
| Amgen Inc. | 5 | $75 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 3 | $32 |
| Dynavax Technologies Corporation | 2 | $31 |
Products named: NURTEC ODT, BREZTRI, Xeomin, UBRELVY, QULIPTA, TRELEGY ELLIPTA, XIFAXAN, OTEZLA.
Industry payments across AR — which companies pay providers there.
